Poly(ADP-ribose) Polymerase Inhibitors [PARP inhibitory]

topical
185
Terms

inhibitor PARP
inhibitory PARP
inhibitory poly-ADP-ribosylace
inhibitory poly(ADP-riboza) polymerázy
PARP inhibitor

 

Inhibitors of Poly(ADP-ribose) Polymerase
Inhibitors of Poly(ADP-ribose) Polymerases
PARP Inhibitor
PARP Inhibitors
Poly(ADP-Ribose) Polymerase Inhibitor
Poly(ADP-ribosylation) Inhibitor
Poly(ADP-ribosylation) Inhibitors

Persistent link   https://www.medvik.cz/link/D000067856
Definition

Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES.

DUI
D000067856 MeSH Browser
CUI
M000601132
History note
2016
Public note
2016

Allowable subheadings

AD
administration & dosage 39
AE
adverse effects 30
AN
analysis
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry 1
CL
classification 2
EC
economics 4
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism 1
PK
pharmacokinetics 7
PD
pharmacology 65
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use 116
TO
toxicity
UR
urine

D Chemicals and Drugs
D27 Chemical Actions and Uses 374
D27.505 Pharmacologic Actions 408
D27.505.519 Molecular Mechanisms of Pharmacological Action 89
D27.505.519.389 Enzyme Inhibitors 873
D27.505.519.389.086 5-Lipoxygenase-Activating Protein Inhibitors 3
D27.505.519.389.089 Acetaldehyde Dehydrogenase Inhibitors 2
D27.505.519.389.092 Adenosine Deaminase Inhibitors 6
D27.505.519.389.108 Adenylyl Cyclase Inhibitors 14
D27.505.519.389.124 Aromatic Amino Acid Decarboxylase Inhibitors 8
D27.505.519.389.174 Calcineurin Inhibitors 122
D27.505.519.389.200 Carbonic Anhydrase Inhibitors 59
D27.505.519.389.237 Catechol O-Methyltransferase Inhibitors 31
D27.505.519.389.275 Cholinesterase Inhibitors 967
D27.505.519.389.310 Cyclooxygenase Inhibitors 454
D27.505.519.389.315 Gamma Secretase Inhibitors and Modulators
D27.505.519.389.320 Glycoside Hydrolase Inhibitors 47
D27.505.519.389.335 Cytochrome P-450 Enzyme Inhibitors 93
D27.505.519.389.350 Folic Acid Antagonists 67
D27.505.519.389.360 Histone Deacetylase Inhibitors 110
D27.505.519.389.370 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 837
D27.505.519.389.375 Integrase Inhibitors 4
D27.505.519.389.400 beta-Lactamase Inhibitors 74
D27.505.519.389.480 Lipoxygenase Inhibitors 51
D27.505.519.389.616 Monoamine Oxidase Inhibitors 155
D27.505.519.389.675 Nucleic Acid Synthesis Inhibitors 33
D27.505.519.389.705 Ornithine Decarboxylase Inhibitors 3
D27.505.519.389.735 Phosphodiesterase Inhibitors 405
D27.505.519.389.736 Phosphoinositide-3 Kinase Inhibitors 31
D27.505.519.389.737 Phospholipase A2 Inhibitors 9
D27.505.519.389.739 Poly(ADP-ribose) Polymerase Inhibitors 185
D27.505.519.389.740 Prolyl-Hydroxylase Inhibitors 3
D27.505.519.389.745 Protease Inhibitors 272
D27.505.519.389.755 Protein Kinase Inhibitors 1 364
D27.505.519.389.760 Protein Synthesis Inhibitors 37
D27.505.519.389.848 Proton Pump Inhibitors 489
D27.505.519.389.870 Steroid Synthesis Inhibitors 1
D27.505.519.389.892 Topoisomerase Inhibitors 7
D27.505.519.389.936 Uncoupling Agents 24
D27.505.954 Therapeutic Uses 61
D27.505.954.248 Antineoplastic Agents 7 734
D27.505.954.248.025 Angiogenesis Inhibitors 630
D27.505.954.248.106 Antibiotics, Antineoplastic 251
D27.505.954.248.125 Anticarcinogenic Agents 119
D27.505.954.248.144 Antimetabolites, Antineoplastic 190
D27.505.954.248.147 Antimitotic Agents 13
D27.505.954.248.150 Antineoplastic Agents, Alkylating 110
D27.505.954.248.169 Antineoplastic Agents, Hormonal 462
D27.505.954.248.179 Antineoplastic Agents, Phytogenic 262
D27.505.954.248.384 Antineoplastic Agents, Immunological 397
D27.505.954.248.538 MTOR Inhibitors 17
D27.505.954.248.589 Myeloablative Agonists 23
D27.505.954.248.692 Poly(ADP-ribose) Polymerase Inhibitors 185
D27.505.954.248.794 Topoisomerase Inhibitors 7

Back Add